Back
Unilever PLC Vs. Novo Nordisk AS Industry Stock Comparison
Buy
53
UL
Unilever PLC
Last Price:
$59.04
Seasonality Move:
3.94%
Sell
30
NONOF
Novo Nordisk AS
Last Price:
$74.16
Seasonality Move:
4.87%
Buy
53
Unilever PLC (UL)
is a Buy
Is Unilever PLC a Buy, Sell or Hold?
-
The current Unilever PLC [UL] share price is $59.33. The Score for UL is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
UL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Novo Nordisk AS (NONOF)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NONOF] share price is $79.09. The Score for NONOF is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
-
NONOF is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
UL Stock Price Chart
What is Unilever PLC's stock price today?
-
The Unilever PLC share price today is $59.33Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UL is experiencing slight selling pressure.
NONOF Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $79.09Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing buying pressure, which is a positive indicator for future bullish movement.
UL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.44 | Buy |
Relative Strength Index (14 RSI): | 61.6 | Buy |
Chaikin Money Flow: | -1024945 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (55.94 - 58.64) | Buy |
Bollinger Bands (100): | (56.18 - 60.56) | Buy |
NONOF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.16 | Buy |
Relative Strength Index (14 RSI): | 38.5 | Sell |
Chaikin Money Flow: | 404837 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (81.79 - 89.61) | Sell |
Bollinger Bands (100): | (83.94 - 109.78) | Sell |
UL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 58 | Buy |
20-day SMA: | 57.18 | Buy |
50-day SMA: | 56.87 | Buy |
200-day SMA: | 59.08 | Buy |
8-day EMA: | 58.18 | Buy |
20-day EMA: | 57.48 | Buy |
50-day EMA: | 57.46 | Buy |
200-day EMA: | 57.52 | Buy |
NONOF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 87.84 | Sell |
20-day SMA: | 85.93 | Sell |
50-day SMA: | 85.07 | Sell |
200-day SMA: | 115.26 | Sell |
8-day EMA: | 86.5 | Sell |
20-day EMA: | 86.55 | Sell |
50-day EMA: | 88.81 | Sell |
200-day EMA: | 104.91 | Sell |
Unilever PLC Earnings Growth & UL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.42 per share, and an increase next year of $0.08 per share.
Novo Nordisk AS Earnings Growth & NONOF Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and a decrease next year of $0.00 per share.
Unilever PLC Technical Analysis
Feb 25 | Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
25 | 26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novo Nordisk AS Technical Analysis
Feb 25 | Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
25 | 26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |